These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Son J; Lyssiotis CA; Ying H; Wang X; Hua S; Ligorio M; Perera RM; Ferrone CR; Mullarky E; Shyh-Chang N; Kang Y; Fleming JB; Bardeesy N; Asara JM; Haigis MC; DePinho RA; Cantley LC; Kimmelman AC Nature; 2013 Apr; 496(7443):101-5. PubMed ID: 23535601 [TBL] [Abstract][Full Text] [Related]
5. Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5. Akuetteh PDP; Huang H; Wu S; Zhou H; Jin G; Hong W; Yang H; Lan L; Shangguan F; Zhang Q J Biochem Mol Toxicol; 2022 Nov; 36(11):e23192. PubMed ID: 35929395 [TBL] [Abstract][Full Text] [Related]
6. Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma. Liu YH; Hu CM; Hsu YS; Lee WH Cell Death Dis; 2022 Sep; 13(9):817. PubMed ID: 36151074 [TBL] [Abstract][Full Text] [Related]
7. Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment. Yamamoto K; Iwadate D; Kato H; Nakai Y; Tateishi K; Fujishiro M Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139512 [TBL] [Abstract][Full Text] [Related]
8. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Hu T; Shukla SK; Vernucci E; He C; Wang D; King RJ; Jha K; Siddhanta K; Mullen NJ; Attri KS; Murthy D; Chaika NV; Thakur R; Mulder SE; Pacheco CG; Fu X; High RR; Yu F; Lazenby A; Steegborn C; Lan P; Mehla K; Rotili D; Chaudhary S; Valente S; Tafani M; Mai A; Auwerx J; Verdin E; Tuveson D; Singh PK Gastroenterology; 2021 Nov; 161(5):1584-1600. PubMed ID: 34245764 [TBL] [Abstract][Full Text] [Related]
9. 4-Hydroxyphenylpyruvate Dioxygenase-Like Protein Promotes Pancreatic Cancer Cell Progression and Is Associated With Glutamine-Mediated Redox Balance. Ye X; Wei X; Liao J; Chen P; Li X; Chen Y; Yang Y; Zhao Q; Sun H; Pan L; Chen G; He X; Lyu J; Fang H Front Oncol; 2020; 10():617190. PubMed ID: 33537239 [TBL] [Abstract][Full Text] [Related]
10. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma. Fu Y; Liu S; Zeng S; Shen H Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370 [TBL] [Abstract][Full Text] [Related]
11. Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze. Olivares O; Vasseur S Int J Cancer; 2016 Feb; 138(4):787-96. PubMed ID: 25732227 [TBL] [Abstract][Full Text] [Related]
12. Heparanase contributes to pancreatic carcinoma progression through insulin-dependent glucose uptake. Abecassis A; Hermano E; Yifrach A; Popovtzer A; Meirovitz A; Elkin M Front Cell Dev Biol; 2023; 11():1287084. PubMed ID: 38078007 [TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets. Andersen HB; Ialchina R; Pedersen SF; Czaplinska D Cancer Metastasis Rev; 2021 Dec; 40(4):1093-1114. PubMed ID: 34855109 [TBL] [Abstract][Full Text] [Related]
14. Aspulvinone O, a natural inhibitor of GOT1 suppresses pancreatic ductal adenocarcinoma cells growth by interfering glutamine metabolism. Sun W; Luan S; Qi C; Tong Q; Yan S; Li H; Zhang Y Cell Commun Signal; 2019 Aug; 17(1):111. PubMed ID: 31470862 [TBL] [Abstract][Full Text] [Related]
15. Pyruvate Kinase Activity Regulates Cystine Starvation Induced Ferroptosis through Malic Enzyme 1 in Pancreatic Cancer Cells. Ensink E; Jordan T; Medeiros HCD; Thurston G; Pardal A; Yu L; Lunt SY bioRxiv; 2023 Sep; ():. PubMed ID: 37745559 [TBL] [Abstract][Full Text] [Related]
17. Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma. Rai V; Agrawal S Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198082 [TBL] [Abstract][Full Text] [Related]
18. Orchestration of mesenchymal plasticity and immune evasiveness Hashimoto A; Handa H; Hata S; Hashimoto S Front Oncol; 2022; 12():1005566. PubMed ID: 36408139 [TBL] [Abstract][Full Text] [Related]
19. Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma. Tang R; Liu X; Wang W; Hua J; Xu J; Liang C; Meng Q; Liu J; Zhang B; Yu X; Shi S Front Oncol; 2021; 11():643465. PubMed ID: 33912458 [TBL] [Abstract][Full Text] [Related]
20. Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC). Xu H; Liu Z; Gao D; Li P; Shen Y; Sun Y; Xu L; Song N; Wang Y; Zhan M; Gao X; Wang Z Mol Metab; 2022 May; 59():101466. PubMed ID: 35219875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]